Silicon was doped to hydroxyapatite by hydrothermal techniques for higher biocompatibility. Products contained tetra-ethyl-orthosilicate (TEOS) as a silicon source in the range of 0 to 15 mass%. In order to evaluate bioactivity of silicon-doped hydroxyapatite, the samples were soaked in simulated body fluid (SBF). Silicon doped samples showed faster apatite forming ability than the undoped samples. The samples were examined by transmission electron microscopy (TEM), X-ray diffraction patterns (XRD), Fourier transform infrared spectroscopy (FTIR) and X-ray absorption fine structure (XAFS). There results indicated that SiO 4 4À ion substituted PO 4 3À ion site in apatite structures. And it was found that appropriate TEOS doping ratio was 10 mass% for superior biocompatibility due to amorphous SiO 2 segregation in the 15 mass% TEOS doped samples.
Introduction
Hydroxyapatite (HAp;[Ca 10 (PO 4 ) 6 (OH) 2 ]) has some advantages as a biomaterial due to its chemical similarity to the inorganic component of the bone and tooth, compared to other ceramics, such as Bioglass and A-W glass. 1) For this reason hydroxyapatite is utilized as a biomaterial to fill bone defects, for bioactive coating for metallic prostheses. 2) However, stoichiometric hydroxyapatite has relatively low ability to associate with existing bone, remaining as a permanent fixture susceptible to long term failure. 3) In general, the mineral in bone is non-stoichiometric, but exhibits variable deficiencies in Ca, P and OH. Especially, the elements such as Si, Mg, Sr and Na are contained to biological apatite, and they play important roles in the biochemistry of bone and tooth. 4) There substitutions can affect the surface structure and charge of hydroxyapatite, leading to influence on the material in biological environments. In vitro and in vivo studies of performed by Carlisle indicated the importance of the silicon on bone formation and calcification. 5) In particular, their study has shown that silicon was localized in active growth areas, such as the osteoid, of the young bone of mice and rats. And it is noted that silicon is essential to the growth and development of biological tissue such as bone, teeth and some invertebrate skeletons. In addition, it has been observed that the doping of Si to hydroxyapatite results in an improvement of the bioactive behavior and advance of bone formation in vivo.
6) Some authors were assuming that Si or SiO 4 4À , replaces P or PO 4 3À , with the subsequent loss of charge equilibrium. 7) In this sense, a one of potential method for improving the bioactivity of hydroxyapatite is the doping of silicon. 8) However, it is important that this doping of the silicon does not result in thermal instability of the silicon doped hydroxyapatite as this effect upon sintering would result in the decomposition of the Si-HAp to undesirable second phase.
Several methods of the synthesis of silicon doped hydroxyapatite have been described. Ruys suggested the use of a sol-gel procedure, however, these materials, in addition to a hydroxyapatite phase, contained calcium silicophosphate and either -or -tricalcium phosphate, depending on the degree of silicon doping.
9) Boyer et al. conducted studies on the silicon-substituted hydroxyapatite by solid state reaction, but in these cases the incorporation of a secondary ion, like lanthanum or sulphate, was needed. 10) Gibson and Kim et al. synthesized silicon-containing hydroxyapatite by using a wet-chemical method, however, sintering at high temperature usually leads to bigger crystal size.
11) Hydrothermal technique usually gives materials with a high degree of crystallinity and with a Ca/P ratio close to stoichiometric hydroxyapatite. 12) Kim et al. reported that a porous silicon incorporated hydroxyapatite had been prepared by hydrothermal treatment and solvothermal treatment of natural coral repeatedly. 13, 14) Our previous study on HAp containing with SiO 2 sol indicated the possibility doping of SiO 2 to HAp by the hydrothermal process. [15] [16] [17] [18] [19] [20] However, it has not come out about state of silicon in the silicon doped hydroxyapatite synthesized by hydrothermal technique. If SiO 2 segregated on surface of the sample, it might lead a danger to public health such as blood coagulation, infection. The purpose of the present study is to bring out about the state and solubility limit of silicon which silicon-doped hydroxyapatite synthesized by hydrothermal technique with various silicon contents. Additionally, chemical characterization of the silicon-doped hydroxyapatite has been carried out.
Experimental
Stoichiometric hydroxyapatite (HAp) and a series of silicon-doped HAp (Si-HAp) were prepared by hydrothermal method using Ca(OH) 2 , H 3 PO 4 and Si(OCH 2 CH 3 ) 4 (TEOS) as starting materials. The amount of reagents was calculated on the assumption that silicon would substitute phosphorus. The starting materials at the Ca/(P+Si) ratio of 1.67 were mixed and at the time TEOS introduced 0, 5, 10, 15 mass%. Ca(OH) 2 , ion exchange water of 25 ml stirred and added H 3 PO 4 , TEOS then hydrothermal treatment at 150 C for 4 days. The resulting products were filtered, dried at 50 C over night in an oven.
* Graduate Student, Osaka Prefecture University
The characterization of the microstructure analysis of HAp and Si-HAp were performed by TEM (JEM2010/SP, JOEL, Japan) with accelerating voltage of 200 kV. The phase composition of HAp and Si-HAp were determined by XRD (RINT 2100, Rigaku Co., Japan), using X-ray diffractometer at 30 kV and 30 mA. Scans were run from 10 to 60 2 at a speed of 2 /min and a step of 1 using Cu K radiation. And the determination of HAp and Si-HAp deviations were performed by FTIR (370DTGS/FT-IR, Nicolet-Avatar Co., Japan). The calcium and phosphorus contents were determined by ICP (ICPS-7000, Shimadzu Co., Japan). The in vitro bioactivity of samples was investigated by soaking them in simulated body fluid (SBF) for various days. The SBF solution was prepared according to the procedure described by Kokubo. 21) The soaking experiment was carried out in a case maintained at 36.5 C, the SBF solution was not refreshed during the experiment. After the pre-selected soaking time, the samples were dried. The microstructures of the samples were observed by SEM (S-4500, Hitachi, Japan) with accelerating voltage of 15 kV. The local structure of samples was investigated by XANES spectra for Ca Kedge, P K-edge, and Si K-edge. Ca K-edge XAFS data for this study was corrected by transmission mode using the Si (111) double crystal monochromater at BL01B1 in the SPring8. The data were collected with the ionization chambers filled with gas (I 0 chamber: He/N 2 = 7/3, I chamber: N 2 ). For the XAFS measurements, the samples were prepared as pellets with the thickness varied to obtain a 0.5-1 jump at the Ca K absorption edge. Cu metallic foil was used for the energy calibration. P K-edge and Si K-edge XANES spectra were recorded in total-electron yield mode using InSb and KTP crystal monochromater at BL1A in UVSOR. The data were collected with the ionization chambers. XANES were analyzed by subtracting a linear background computed by least-squares fitting. The analysis of XANES data was conducted using the commercial software ''REX2000'' (Rigaku Co. Ltd., Japan).
Results and Discussion
The doping mechanism of silicon to HAp would describe the substitution of a phosphate group for a silicate group, with an appropriate mechanism for charge balance, is given in eq. (1):
To compensate for the extra negative charge of the silicate groups, some of the OH À groups would be lost to retain charge balance. Figure 1 shows TEM images of the products prepared by hydrothermal technique. As shown in Fig. 1 , the pure HAp was rod-shaped. However, Si doped samples became spherical-shaped with increasing TEOS content. The value of crystal size decreases with the TEOS addition. Figure 2 shows XRD pattern of the products prepared by hydrothermal technique. The silicon doping did not appear to affect the diffraction pattern of hydroxyapatite. The pattern of the all samples appeared to be identical, without secondary phase, such as TCP or SiO 2 . All the diffraction peak of samples matched the standard for hydroxyapatite. However, these reflections become slightly broad and less intense as the TEOS addition. The reason could be the result of degradation of crystallinity attributed to the formation of hydroxyl vacancy caused by the substitution of PO 4 3À by SiO 4 4À . It also could be caused by the decrease of crystal size. This result suggested the substitution of silicon into the hydroxyapatite lattice.
FTIR was evaluated to confirm the effect of the silicon substitution on the different functional groups, such as hydroxyl and phosphate groups of hydroxyapatite. Figure 3 shows the FTIR spectra of prepared samples. First, the bands at 3571 cm À1 and 631 cm À1 corresponded to the hydroxyl group stretching and vibrational modes, respectively. The intense bands at 962 cm À1 corresponded to P-O stretching corresponds to the O-P-O bending mode. 22) Furthermore, the broad band at 3500 cm À1 was assigned to moisture in the samples. The FTIR spectra of Si-HAp samples showed several significant changes from the synthesized HAp. The notable effect of silicon doped hydroxyapatite on FTIR was the decrease in the hydroxyl stretching bands at 3571 cm À1 and 631 cm À1 and phosphate stretching bands at 962 cm
À1
with increasing TEOS content. Moreover, new band appearing at 800 cm À1 only for Si-HAp, was assigned to Si-O-Si vibration modes of SiO 4 4À groups which have been polymerized. 23) According to eq. (1), incorporation of silicon into the hydroxyapatite structure (Ca 10 (PO 4 ) 6Àx (SiO 4 ) x (OH) 2Àx ) reduces the amount of hydroxyl groups for compensating for the extra negative charge of the silicate group. There result suggest that incorporation of silicon into some of the phosphorous sites in the lattice results in changes in the bonding and symmetry of the phosphate groups, charge is compensated by loss of OH À . Table 1 lists Ca/P molar ratio of prepared samples set up by ICP analysis. Ca/P molar ratio increased with increasing TEOS content. It could be the result of the decrease phosphate groups by addition of silicon. Furthermore, all Si-HAp samples were confirmed the existence of silicon. These results also show that PO 4 3À tetrahedrons are replaced by SiO 4 4À tetrahedrons in the hydroxyapatite structure.
The compactions of synthesized samples were soaked in SBF solution to evaluate their bioactivity. Figure 4 shows SEM images of the samples after immersion in SBF for various periods. There were observed the notable precipitation of bone-like apatite on the surface of 5 mass% Si-HAp after 3 days immersion, 10 mass% Si-HAp after 2 days immersion and 15 mass% Si-HAp after 1 day immersion. However, silicon undoped sample only have no change after soaking SBF for any periods. From this result, it found that the biocompatibility of samples was improved by TEOS addition and the formation of bone like apatite more accelerated with increasing TEOS content. And it also suggested that the substitution of silicon for HAp can affect the surface structure, surface charge, and solubility of HAp, which can, result in changes in the biological performance in vitro. The characterization of surface charge and adsorption for silicon doped HAp is now under investigation.
The local structure of near Ca, P, Si atoms were evaluated by XAFS to circumstantially examine the state of doping silicon to HAp. Figure 5(A) shows the first derivative of functions to Ca K-edge XANES spectra for Si-HAp and commercial HAp as a reference sample. The spectra of synthesized all samples were very close to the peak position of commercial HAp. This result indicated that the local structure of near Ca atoms in all Si-HAp were similar to HAp regardless of TEOS content. Figure 5(B) shows the first derivative of functions of P K-edge XANES spectra for SiHAp and commercial HAp. The energy position of adsorption edge of silicon doping HAp shifted to high energy side. As previously mentioned, FTIR showed that PO 4 3À groups were replaced by SiO 4 4À groups in the hydroxyapatite structure with the TEOS addition, charge balance was maintained by loss of OH À . This reaction could be caused the change of electron state which the local structure of near P atoms, leading to shift of the energy position of adsorption edge. Besides, Fig. 5(C) shows the first derivative of functions of Si K-edge for silicon doping HAp and commercial amorphous SiO 2 as a reference. The energy position of adsorption edge of Si K-edge of 5 and 10 mass% Si-HAp were agreed, however, 15 mass% Si-HAp sifted to amorphous SiO 2 side. From this result, it suggested that a doping TEOS for from 5 to 10 mass% Si-HAp were substituted to phosphate groups in the hydroxyapatite structure, and for 15 mass% Si-HAp in part TEOS was segregated as amorphous SiO 2 . Therefore, it could be caused the increase of biocompatibility for 15 mass% Si-HAp by both segregated amorphous SiO 2 and doping SiO 2 into HAp, leading to the good bioactivity of bioactive glasses and glass-ceramics.
Conclusion
Silicon doping hydroxyapatite powder were prepared by hydrothermal method using Ca(OH) 2 , H 3 PO 4 and Si(OCH 2 CH 3 ) 4 (TEOS) as reagents. The analysis of TEM, XRD, FTIR and ICP shows that the substitution of silicate groups for the phosphate groups causes some OH À loss to maintain the charge balance. Furthermore, the synthesized samples were soaked in SBF solution to evaluate their bioactivity. The silicon doping HAp presented superior bioactivity with increasing silicon content. However, the analysis of XAFS suggested that 15 mass% Si-HAp segregated amorphous SiO 2 . Therefore, 5 and 10 mass% Si-HAp could be applied for biomaterial that had superior biocompatibility than 15 mass% Si-HAp for living body. Synthesis and Characterization of Silicon-Doped Hydroxyapatite
